You’re invited: Strategic Plan 2025-2028 launch virtual forum Leading with purpose, a clear direction, a bold ambition, and a shared…
FIND OUT MOREThe BioForum ‘Stepping off the ledge: Quantum, AI technologies and the future of drug discovery’, delivered by BioMelbourne Network, will…
FIND OUT MOREPosted: 12 June 2025 Chimeric Therapeutics Limited (ASX:CHM), an Australian leader in cell therapy, announced the receipt of $2,500,000 from…
READ MOREPosted: 11 June 2025 Positive top-line results from a Phase 2 clinical trial were announced by Akaal Pharma Pty Ltd…
READ MOREPosted: 11 June 2025 The Company: The client of our BioMelbourne Network member mexec, is a biotechnology company with a…
READ MORE